Is there a role for apheresis in gastrointestinal disorders?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 2, Issue 5, 2005, Pages 200-201

  Hibi, Toshifumi ^a   Sakuraba, Atsushi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; CORTICOSTEROID; MERCAPTOPURINE;

ALCOHOL LIVER DISEASE; APHERESIS; BEHCET DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DEVICE; DOWN REGULATION; ENTERITIS; GASTROINTESTINAL DISEASE; GRANULOCYTE; HEPATITIS C; HUMAN; ILEITIS; LEUKAPHERESIS; LEUKOCYTE COUNT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

BLOOD COMPONENT REMOVAL; GASTROINTESTINAL DISEASES; HUMANS; TREATMENT OUTCOME;

EID: 20444452917     PISSN: 17434378     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpgasthep0168     Document Type: Review

References (10)

1. Takazoe M et al. (2002) The present status and the recent development of the treatment for inflammatory bowel diseases: desirable effect of extracorporeal immunomodulation. Ther Apher 6: 305-311
2. Holdstock GE et al. (1979) Plasmapheresis in Crohn's disease. Digestion 19: 197-201
3. Bicks RO and Groshart KD (1989) The current status of T-lymphocyte apheresis (TLA) treatment of Crohn's disease. J Clin Gastroenterol 11: 136-138
4. Lerebours E et al. (11994) Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives Gastroenterology 107: 357-361
5. Fukuda Y et al. (2004) Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. J Gastroenteol 39: 1158-1164
6. Simoyama T et al. (1999) Granulocyte and monocyte apheresis with the G-1 column in the treatment of patients with active ulcerative colitis (Abstract). Jpn J Apheresis 18: 117-131
7. Sawada K et al. (2003) Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 9: 307-321
8. Sawada K et al. Leukocytapheresis in Ulcerative Colitis: Results of a Multicenter Double-blind Prospective Case-control Study with Sham Apheresis as Placebo Treatment. Am J Gastroenterol, in press
9. Suzuki Y et al. (2004) Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 49: 565-571
10. Naganuma M et al. (2004) Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis 10: 251-257